Mayne Pharma Group Limited

OTCPK:MAYN.F Stock Report

Market Cap: US$236.3m

Mayne Pharma Group Management

Management criteria checks 2/4

Mayne Pharma Group's CEO is Shawn O’Brien, appointed in Oct 2022, has a tenure of 2.08 years. total yearly compensation is A$2.06M, comprised of 46.5% salary and 53.5% bonuses, including company stock and options. directly owns 0.075% of the company’s shares, worth $177.19K. The average tenure of the management team and the board of directors is 2.8 years and 2.7 years respectively.

Key information

Shawn O’Brien

Chief executive officer

AU$2.1m

Total compensation

CEO salary percentage46.5%
CEO tenure2.1yrs
CEO ownership0.07%
Management average tenure2.8yrs
Board average tenure2.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Shawn O’Brien's remuneration changed compared to Mayne Pharma Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$2mAU$959k

-AU$169m

Mar 31 2024n/an/a

-AU$221m

Dec 31 2023n/an/a

-AU$274m

Sep 30 2023n/an/a

-AU$296m

Jun 30 2023AU$2mAU$663k

-AU$317m

Compensation vs Market: Shawn's total compensation ($USD1.34M) is about average for companies of similar size in the US market ($USD1.46M).

Compensation vs Earnings: Shawn's compensation has increased whilst the company is unprofitable.

CEO

Shawn O’Brien (65 yo)

2.1yrs

Tenure

AU$2,062,194

Compensation

Mr. Shawn Patrick O'Brien, B.Sc has been CEO, MD & Director at Mayne Pharma Group Limited since October 1, 2022. He serves as the Chief Commercial Advisor at Melanovus Oncology, Inc. Mr. O'Brien is a found...

Leadership Team

NamePositionTenureCompensationOwnership
Shawn O’Brien
CEO, MD & Director2.1yrsAU$2.06m0.075%
$ 177.2k
Aaron Gray
Chief Financial Officer2.3yrsAU$1.31m0.064%
$ 150.5k
Kimberly Parker
Executive VP & General Counsel2.8yrsno datano data
Brant Schofield
Executive Vice President of Corporate Development3.8yrsAU$1.29mno data
Erinn Nathaniel
Director of Global Human Resources1.8yrsno datano data
Daniel Moore
Executive Vice President of Commercial5.2yrsno datano data
Frank Casty
Executive VP & Global Chief Medical Officer1.8yrsno datano data
Brenton Walter
Financial Controller20.3yrsno datano data
Laura Loftus
Associate General Counsel & Company Secretary4.7yrsno datano data

2.8yrs

Average Tenure

Experienced Management: MAYN.F's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Shawn O’Brien
CEO, MD & Director2.1yrsAU$2.06m0.075%
$ 177.2k
Frank Condella
Independent Non-Executive Chairman6.5yrsAU$305.40k0.081%
$ 192.0k
Bruce Robinson
Independent Non-Executive Director10.3yrsAU$219.39k0.039%
$ 92.4k
Patrick Blake
Independent Non-Executive Director6.4yrsAU$218.36k0.027%
$ 64.3k
Ann Custin
Independent Non-Executive Director2.7yrsAU$235.16k0.026%
$ 62.2k
Kathryn MacFarlane
Independent Non-Executive Director2.8yrsAU$215.84k0.047%
$ 110.6k
Anne Lockwood
Independent Non Executive Directorless than a yearAU$117.49kno data
David Petrie
Non-Executive Director2.2yrsAU$217.86kno data

2.7yrs

Average Tenure

62yo

Average Age

Experienced Board: MAYN.F's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.